SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-22-000007
Filing Date
2022-03-07
Accepted
2022-03-07 16:19:04
Documents
15
Period of Report
2022-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca-20220303.htm   iXBRL 8-K 38994
2 EX-99.1 ex-99120220307.htm EX-99.1 7672
6 gnca-20220303_g1.jpg GRAPHIC 16581
7 image_0.jpg GRAPHIC 63512
  Complete submission text file 0001457612-22-000007.txt   321681

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20220303.xsd EX-101.SCH 1947
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20220303_lab.xml EX-101.LAB 25250
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20220303_pre.xml EX-101.PRE 13179
9 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20220303_htm.xml XML 11008
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 22718241
SIC: 2836 Biological Products, (No Diagnostic Substances)